{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:50:30Z","timestamp":1789584630972,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56469-7","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:23:22Z","timestamp":1740133402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early Alzheimer\u2019s Disease with frequent neuritic plaques harbors neocortical tau seeds distinct from primary age-related tauopathy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-4508","authenticated-orcid":false,"given":"Danielle F.","family":"Browne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis S.","family":"Smirnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4111-0102","authenticated-orcid":false,"given":"David G.","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi G.","family":"Standke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongya","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Unapanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-6610","authenticated-orcid":false,"given":"Annie","family":"Hiniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8477-0894","authenticated-orcid":false,"given":"Allison","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"56469_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.dadm.2019.07.007","volume":"11","author":"J Ziontz","year":"2019","unstructured":"Ziontz, J. et al. Tau pathology in cognitively normal older adults. Alzheimers Dement (Amst.) 11, 637\u2013645 (2019).","journal-title":"Alzheimers Dement (Amst.)"},{"key":"56469_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"56469_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"56469_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Eisenberg, D. S. & Crowther, R. A. Propagation of Tau Aggregates and Neurodegeneration. Annu. Rev. Neurosci. 40, 189\u2013210 (2017).","journal-title":"Annu. Rev. Neurosci."},{"key":"56469_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker, M. & Walker, L. C. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nat. Neurosci. 21, 1341\u20131349 (2018).","journal-title":"Nat. Neurosci."},{"key":"56469_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","volume":"598","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359\u2013363 (2021).","journal-title":"Nature"},{"key":"56469_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary, J. F. et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 128, 755\u2013766 (2014).","journal-title":"Acta Neuropathol."},{"key":"56469_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-015-1407-2","volume":"129","author":"KA Jellinger","year":"2015","unstructured":"Jellinger, K. A. et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 129, 757\u2013762 (2015).","journal-title":"Acta Neuropathol."},{"key":"56469_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","volume":"141","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease with PET ligand APN-1607. Acta Neuropathol. 141, 697\u2013708 (2021).","journal-title":"Acta Neuropathol."},{"key":"56469_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12788","volume":"48","author":"S Savola","year":"2022","unstructured":"Savola, S. et al. Primary age-related tauopathy in a Finnish population-based study of the oldest old (Vantaa 85+). Neuropathol. Appl. Neurobiol. 48, e12788 (2022).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"56469_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-018-1872-5","volume":"136","author":"JL Robinson","year":"2018","unstructured":"Robinson, J. L. et al. Non-Alzheimer\u2019s contributions to dementia and cognitive resilience in The 90+ Study. Acta Neuropathol. 136, 377\u2013388 (2018).","journal-title":"Acta Neuropathol."},{"key":"56469_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jnen\/nlab113","volume":"81","author":"JM Walker","year":"2022","unstructured":"Walker, J. M., White, C. L., Farrell, K., Crary, J. F. & Richardson, T. E. Neocortical Neurofibrillary degeneration in primary age-related tauopathy. J. Neuropathol. Exp. Neurol. 81, 146\u2013148 (2022).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"56469_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jalz.2018.07.215","volume":"15","author":"WR Bell","year":"2019","unstructured":"Bell, W. R. et al. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer\u2019s disease. Alzheimers Dement 15, 8\u201316 (2019).","journal-title":"Alzheimers Dement"},{"key":"56469_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/jnen\/nly132","volume":"78","author":"LM Besser","year":"2019","unstructured":"Besser, L. M. et al. Differences in cognitive impairment in primary age-related tauopathy Versus Alzheimer Disease. J. Neuropathol. Exp. Neurol. 78, 219\u2013228 (2019).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"56469_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41374-019-0186-0","volume":"99","author":"M Teylan","year":"2019","unstructured":"Teylan, M. et al. Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer\u2019s neuropathology. Lab Invest 99, 1049\u20131055 (2019).","journal-title":"Lab Invest"},{"key":"56469_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/BF00296494","volume":"88","author":"C Bancher","year":"1994","unstructured":"Bancher, C. & Jellinger, K. A. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol. 88, 565\u2013570 (1994).","journal-title":"Acta Neuropathol."},{"key":"56469_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00401-006-0156-7","volume":"113","author":"KA Jellinger","year":"2007","unstructured":"Jellinger, K. A. & Attems, J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol. 113, 107\u2013117 (2007).","journal-title":"Acta Neuropathol."},{"key":"56469_CR18","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1212\/WNL.0000000000013107","volume":"98","author":"DS Smirnov","year":"2022","unstructured":"Smirnov, D. S. et al. Association of neurofibrillary tangle distribution with age at onset-related clinical heterogeneity in alzheimer disease: an autopsy study. Neurology 98, e506\u2013e517 (2022).","journal-title":"Neurology"},{"key":"56469_CR19","doi-asserted-by":"crossref","unstructured":"Manca, M. et al. Tau seeds occur before earliest Alzheimer\u2019s changes and are prevalent across neurodegenerative diseases. Acta Neuropathol. 146, 31\u201350 (2023).","DOI":"10.1007\/s00401-023-02574-0"},{"key":"56469_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00441-022-03595-z","volume":"392","author":"HG Standke","year":"2023","unstructured":"Standke, H. G. & Kraus, A. Seed amplification and RT-QuIC assays to investigate protein seed structures and strains. Cell Tissue Res. 392, 323\u2013335 (2023).","journal-title":"Cell Tissue Res"},{"key":"56469_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00401-018-1947-3","volume":"137","author":"A Kraus","year":"2019","unstructured":"Kraus, A. et al. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease. Acta Neuropathol. 137, 585\u2013598 (2019).","journal-title":"Acta Neuropathol."},{"key":"56469_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","volume":"136","author":"SK Kaufman","year":"2018","unstructured":"Kaufman, S. K., Del Tredici, K., Thomas, T. L., Braak, H. & Diamond, M. I. Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol. 136, 57\u201367 (2018).","journal-title":"Acta Neuropathol."},{"key":"56469_CR23","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","volume":"187","author":"RE Bennett","year":"2017","unstructured":"Bennett, R. E. et al. Enhanced Tau Aggregation in the Presence of Amyloid beta. Am. J. Pathol. 187, 1601\u20131612 (2017).","journal-title":"Am. J. Pathol."},{"key":"56469_CR24","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling, H. et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s Disease. Cell 183, 1699\u20131713.e1613 (2020).","journal-title":"Cell"},{"key":"56469_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker Changes during 20 Years Preceding Alzheimer\u2019s Disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med"},{"key":"56469_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia, Y., Prokop, S. & Giasson, B. I. Don\u2019t Phos Over Tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol. Neurodegener. 16, 37 (2021).","journal-title":"Mol. Neurodegener."},{"key":"56469_CR27","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney, C. M., Lowe, V. J. & Murray, M. E. Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research. Alzheimers Dement 17, 1554\u20131574 (2021).","journal-title":"Alzheimers Dement"},{"key":"56469_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-020-0887-z","volume":"8","author":"MA Metrick","year":"2020","unstructured":"Metrick, M. A. et al. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases. Acta Neuropathol. Commun. 8, 22 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"56469_CR29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","volume":"66","author":"PT Nelson","year":"2007","unstructured":"Nelson, P. T. et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity. J. Neuropathol. Exp. Neurol. 66, 1136\u20131146 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"56469_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele, R. et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain 139, 1551\u20131567 (2016).","journal-title":"Brain"},{"key":"56469_CR31","doi-asserted-by":"crossref","unstructured":"Ioannou, K. et al. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer\u2019s disease compared to comorbid cases; proof of concept in the ADNI study. Mol Psychiatry (2024).","DOI":"10.1038\/s41380-024-02672-9"},{"key":"56469_CR32","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00401-022-02472-x","volume":"144","author":"S Arezoumandan","year":"2022","unstructured":"Arezoumandan, S. et al. Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer\u2019s disease. Acta Neuropathol. 144, 1103\u20131116 (2022).","journal-title":"Acta Neuropathol."},{"key":"56469_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13024-017-0229-1","volume":"12","author":"E Ercan","year":"2017","unstructured":"Ercan, E. et al. A validated antibody panel for the characterization of tau post-translational modifications. Mol. Neurodegener. 12, 87 (2017).","journal-title":"Mol. Neurodegener."},{"key":"56469_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68\u201380 (2021).","journal-title":"Lancet Neurol."},{"key":"56469_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/NEN.0b013e31817275c7","volume":"67","author":"G Basurto-Islas","year":"2008","unstructured":"Basurto-Islas, G. et al. Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J. Neuropathol. Exp. Neurol. 67, 470\u2013483 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"56469_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39328-1","volume":"14","author":"N Kyalu Ngoie Zola","year":"2023","unstructured":"Kyalu Ngoie Zola, N. et al. Specific post-translational modifications of soluble tau protein distinguishes Alzheimer\u2019s disease and primary tauopathies. Nat. Commun. 14, 3706 (2023).","journal-title":"Nat. Commun."},{"key":"56469_CR37","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1074\/jbc.M114.627919","volume":"290","author":"J Rosseels","year":"2015","unstructured":"Rosseels, J. et al. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics. J. Biol. Chem. 290, 4059\u20134074 (2015).","journal-title":"J. Biol. Chem."},{"key":"56469_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00441-022-03665-2","volume":"392","author":"AJ Block","year":"2023","unstructured":"Block, A. J. & Bartz, J. C. Prion strains: shining new light on old concepts. Cell Tissue Res. 392, 113\u2013133 (2023).","journal-title":"Cell Tissue Res"},{"key":"56469_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30458-6","volume":"13","author":"F Hoyt","year":"2022","unstructured":"Hoyt, F. et al. Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat. Commun. 13, 4005 (2022).","journal-title":"Nat. Commun."},{"key":"56469_CR40","doi-asserted-by":"publisher","first-page":"e1010947","DOI":"10.1371\/journal.ppat.1010947","volume":"18","author":"F Hoyt","year":"2022","unstructured":"Hoyt, F. et al. Cryo-EM of prion strains from the same genotype of host identifies conformational determinants. PLoS Pathog. 18, e1010947 (2022).","journal-title":"PLoS Pathog."},{"key":"56469_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30457-7","volume":"13","author":"SW Manka","year":"2022","unstructured":"Manka, S. W. et al. 2.7 A cryo-EM structure of ex vivo RML prion fibrils. Nat. Commun. 13, 4004 (2022).","journal-title":"Nat. Commun."},{"key":"56469_CR42","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1093\/brain\/awad272","volume":"146","author":"A Tarutani","year":"2023","unstructured":"Tarutani, A. et al. Distinct tau folds initiate templated seeding and alter the post-translational modification profile. Brain 146, 4988\u20134999 (2023).","journal-title":"Brain"},{"key":"56469_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh1448","volume":"7","author":"G Meisl","year":"2021","unstructured":"Meisl, G. et al. In vivo rate-determining steps of tau seed accumulation in Alzheimer\u2019s disease. Sci. Adv. 7, eabh1448 (2021).","journal-title":"Sci. Adv."},{"key":"56469_CR44","first-page":"86","volume":"132","author":"DW Dickson","year":"1988","unstructured":"Dickson, D. W. et al. Alzheimer\u2019s disease. A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132, 86\u2013101 (1988).","journal-title":"Am. J. Pathol."},{"key":"56469_CR45","doi-asserted-by":"crossref","unstructured":"Tsering, W. & Prokop, S. Neuritic Plaques - Gateways to Understanding Alzheimer\u2019s Disease. Mol. Neurobiol 61, 2808\u20132821 (2023).","DOI":"10.1007\/s12035-023-03736-7"},{"key":"56469_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray, M. E. et al. Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10, 785\u2013796 (2011).","journal-title":"Lancet Neurol."},{"key":"56469_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman, B. T. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8, 1\u201313 (2012).","journal-title":"Alzheimers Dement"},{"key":"56469_CR48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ana.410140502","volume":"14","author":"RD Terry","year":"1983","unstructured":"Terry, R. D. & Katzman, R. Senile dementia of the Alzheimer type. Ann. Neurol. 14, 497\u2013506 (1983).","journal-title":"Ann. Neurol."},{"key":"56469_CR49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"56469_CR50","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal, D. R., Rub, U., Orantes, M. & Braak, H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58, 1791\u20131800 (2002).","journal-title":"Neurology"},{"key":"56469_CR51","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"56469_CR52","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/archneur.1994.00540210060013","volume":"51","author":"D Galasko","year":"1994","unstructured":"Galasko, D. et al. Clinical-neuropathological correlations in Alzheimer\u2019s disease and related dementias. Arch. Neurol. 51, 888\u2013895 (1994).","journal-title":"Arch. Neurol."},{"key":"56469_CR53","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A. & Martin, R. L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140, 566\u2013572 (1982).","journal-title":"Br. J. Psychiatry"},{"key":"56469_CR54","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"56469_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement"},{"key":"56469_CR56","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/jnen\/nlac094","volume":"81","author":"DG Coughlin","year":"2022","unstructured":"Coughlin, D. G. et al. Digital histological study of neocortical grey and white matter tau burden across tauopathies. J. Neuropathol. Exp. Neurol. 81, 953\u2013964 (2022).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"56469_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"56469_CR58","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/nan.12659","volume":"46","author":"DG Coughlin","year":"2020","unstructured":"Coughlin, D. G. et al. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 46, 707\u2013721 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"56469_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin, D. et al. Cognitive and pathological influences of tau pathology in lewy body disorders. Ann. Neurol. 85, 259\u2013271 (2019).","journal-title":"Ann. Neurol."},{"key":"56469_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/jnen\/nlab032","volume":"80","author":"JM Walker","year":"2021","unstructured":"Walker, J. M. et al. Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease. J. Neuropathol. Exp. Neurol. 80, 436\u2013445 (2021).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"56469_CR61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-022-02480-x","volume":"144","author":"DG Coughlin","year":"2022","unstructured":"Coughlin, D. G. et al. Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer\u2019s disease. Acta Neuropathol. 144, 789\u2013792 (2022).","journal-title":"Acta Neuropathol."},{"key":"56469_CR62","unstructured":"Dougherty, R. M. Animal virus titration techniques. in Techniques in experimental virology (ed. Harris, R. J. C.) 183-186 (New York: Academic Press Inc, 1964)."},{"key":"56469_CR63","doi-asserted-by":"publisher","first-page":"e2076","DOI":"10.1212\/WNL.0000000000009434","volume":"94","author":"DS Smirnov","year":"2020","unstructured":"Smirnov, D. S. et al. Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology 94, e2076\u2013e2087 (2020).","journal-title":"Neurology"},{"key":"56469_CR64","unstructured":"Kraus, A. Created in BioRender, https:\/\/BioRender.com\/f48t930 (2024)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56469-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56469-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56469-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:25:39Z","timestamp":1740133539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56469-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56469"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56469-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K. is a co-inventor on patent US11906530B2 and pending application describing seed amplification methods to detect tau seeds. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1851"}}